![Daniel Janse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Janse
Chief Executive Officer at
Affyimmune Therapeutics, Inc.
Profile
Daniel Janse is currently the President & Chief Executive Officer at Affyimmune Therapeutics, Inc. He previously held positions as the Director at Cell Therapy Ltd. in 2011, Senior Director at Juno Therapeutics GmbH from 2016 to 2018, Managing Director at Northpond Ventures LLC in 2023, Senior Director at Johnson & Johnson Innovation from 2013 to 2016, Manager at McKinsey & Co., Inc. from 2008 to 2011, Investment Manager at Inventages Venture Capital Investment, Inc. from 2011 to 2013, and Chief Operating Officer at Arbor Biotechnologies, Inc. from 2020 to 2021.
Dr. Janse obtained his undergraduate degree from Brown University in 1998 and his doctorate degree from Harvard University in 2005.
Daniel Janse active positions
| Companies | Position | Start |
|---|---|---|
Affyimmune Therapeutics, Inc.
 Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing engineered immune cells to fight cancer disease | Chief Executive Officer | 15/07/2024 |
Former positions of Daniel Janse
| Companies | Position | End |
|---|---|---|
Northpond Ventures LLC
 Northpond Ventures LLC Investment ManagersFinance Northpond Ventures invests in companies located in the United States. The firm focuses on the science and technology sectors. It participates in early-stage capital transactions. | Director/Board Member | 01/01/2023 |
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Chief Operating Officer | 31/05/2021 |
Juno Therapeutics GmbH
 Juno Therapeutics GmbH BiotechnologyHealth Technology Develops CAR-T therapy candidates for the treatment of various types of cancer | Private Equity Investor | 31/07/2018 |
Johnson & Johnson Innovation LLC
 Johnson & Johnson Innovation LLC Medical/Nursing ServicesHealth Services Provides healthcare solutions and services | Private Equity Investor | 30/09/2016 |
Inventages Venture Capital Investment, Inc
 Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture invests in companies located across the globe. The firm targets companies operating in the fields of diagnostics, drugs, OTC, medical and functional foods, nutraceuticals and enabling technologies. It provides financing for seed and early stage capital requirements. | Corporate Officer/Principal | 31/07/2013 |
Training of Daniel Janse
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inventages Venture Capital Investment, Inc
Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture invests in companies located across the globe. The firm targets companies operating in the fields of diagnostics, drugs, OTC, medical and functional foods, nutraceuticals and enabling technologies. It provides financing for seed and early stage capital requirements. | Finance |
Cell Therapy Ltd.
 Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Health Technology |
Johnson & Johnson Innovation LLC
Johnson & Johnson Innovation LLC Medical/Nursing ServicesHealth Services Provides healthcare solutions and services | Health Services |
Juno Therapeutics GmbH
Juno Therapeutics GmbH BiotechnologyHealth Technology Develops CAR-T therapy candidates for the treatment of various types of cancer | Health Technology |
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Health Technology |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures invests in companies located in the United States. The firm focuses on the science and technology sectors. It participates in early-stage capital transactions. | Finance |
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing engineered immune cells to fight cancer disease | Commercial Services |
- Stock Market
- Insiders
- Daniel Janse
